Clinical Trial Update: Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing avelumab plus standard chemoradiotherapy versus chemoradiotherapy alone in locally advanced head and neck squamous cell carcinoma; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Avelumab (avelumab)

Snippet

Sponsor: Pfizer | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 3 | Status: TERMINATED | Results posted: 2021-02-24